AstraZeneca choisit le marché de l'obésité pour poursuivre sa croissance
www.thepharmaletter.com/article/stro...
2 years ago
2
0
0
0
Posts by Listing
The HLA-E/NKG2A axis is a dominant immunomodulatory pathway associated with distinct tumor microenvironment features in a subset of NSCLC | Journal for ImmunoTherapy of Cancer
Authors form Yale & AstraZeneca
#NKG2A #NSCLC
2 years ago
1
0
0
0
😢
2 years ago
0
0
0
0
Hello ! 👋🏼
2 years ago
2
0
0
0